Skip to content

Drug interactions

Dronedarone + Rimegepant

Severity: Moderate

Dronedarone and Rimegepant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dronedarone inhibits P-glycoprotein and may increase rimegepant exposure, which is a P-gp substrate. Higher levels may increase adverse effects such as nausea and hypersensitivity.

What this interaction means in plain words

Dronedarone and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dronedarone belongs to Cardiovascular; Rimegepant belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

P-glycoprotein inhibition by dronedarone reduces rimegepant efflux and increases exposure.

What to do

Avoid a second rimegepant dose within 48 hours when given with a P-gp inhibitor, per labeling.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dronedarone and Rimegepant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dronedarone with Rimegepant?

MediHelp rates the interaction as moderate. Dronedarone and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dronedarone inhibits P-glycoprotein and may increase rimegepant exposure, which is a P-gp substrate. Higher levels may increase adverse effects such as nausea and hypersensitivity.

How serious is the interaction between Dronedarone and Rimegepant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid a second rimegepant dose within 48 hours when given with a P-gp inhibitor, per labeling.

What other medicines interact with Dronedarone?

MediHelp also lists interactions of Dronedarone with, for example, Adagrasib, Amiodarone, Arsenic trioxide. The full list is on the Dronedarone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in